| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.22 | 0.09 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |